A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study
Casal Rubio, J., Fírvida-Pérez, J. L., Lázaro-Quintela, M., Barón-Duarte, F. J., Alonso-Jáudenes, G., Santomé, L., Afonso-Afonso, F. J., Amenedo, M., Huidobro, G., Campos-Balea, B., López-Vázquez, M.Volume:
73
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-013-2370-z
Date:
March, 2014
File:
PDF, 439 KB
english, 2014